deferoxamine has been researched along with Cancer of Esophagus in 3 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The current study is aimed at investigating the functional property of ferulic acid (FA, a phenolic acid substance) on inducing ferroptosis in antiesophageal squamous cell carcinoma (ESCC)." | 8.12 | Ferulic Acid Mitigates Growth and Invasion of Esophageal Squamous Cell Carcinoma through Inducing Ferroptotic Cell Death. ( Cao, Y; Tang, J; Wang, R; Zhang, H, 2022) |
| " The current study is aimed at investigating the functional property of ferulic acid (FA, a phenolic acid substance) on inducing ferroptosis in antiesophageal squamous cell carcinoma (ESCC)." | 4.12 | Ferulic Acid Mitigates Growth and Invasion of Esophageal Squamous Cell Carcinoma through Inducing Ferroptotic Cell Death. ( Cao, Y; Tang, J; Wang, R; Zhang, H, 2022) |
| "Deferoxamine (DFO) was found to modulate multiple cellular pathways involved in the growth of breast cancer, hepatocellular carcinoma, lung cancer and bladder cancer." | 1.48 | Deferoxamine suppresses esophageal squamous cell carcinoma cell growth via ERK1/2 mediated mitochondrial dysfunction. ( Chen, X; Gao, Y; Guo, M; Huang, D; Lan, L; Liu, Y; Lu, B; Lu, J; Mo, S; Niu, L; Wei, W; Zheng, Y, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y | 1 |
| Zhang, H | 1 |
| Tang, J | 1 |
| Wang, R | 1 |
| Lan, L | 1 |
| Wei, W | 1 |
| Zheng, Y | 1 |
| Niu, L | 1 |
| Chen, X | 1 |
| Huang, D | 1 |
| Gao, Y | 1 |
| Mo, S | 1 |
| Lu, J | 1 |
| Guo, M | 1 |
| Liu, Y | 1 |
| Lu, B | 1 |
| Ford, SJ | 1 |
| Obeidy, P | 1 |
| Lovejoy, DB | 1 |
| Bedford, M | 1 |
| Nichols, L | 1 |
| Chadwick, C | 1 |
| Tucker, O | 1 |
| Lui, GY | 1 |
| Kalinowski, DS | 1 |
| Jansson, PJ | 1 |
| Iqbal, TH | 1 |
| Alderson, D | 1 |
| Richardson, DR | 1 |
| Tselepis, C | 1 |
3 other studies available for deferoxamine and Cancer of Esophagus
| Article | Year |
|---|---|
Ferulic Acid Mitigates Growth and Invasion of Esophageal Squamous Cell Carcinoma through Inducing Ferroptotic Cell Death.
Topics: Caspase 3; Deferoxamine; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Ferroptosis; Huma | 2022 |
Deferoxamine suppresses esophageal squamous cell carcinoma cell growth via ERK1/2 mediated mitochondrial dysfunction.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Movement; Cell Proliferation; Deferoxamine; Esoph | 2018 |
Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Cell Line | 2013 |